Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform
- PMID: 2010047
- DOI: 10.2337/diab.40.4.472
Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform
Abstract
We investigated the mechanism of peripheral insulin resistance in the adipose tissue of obese and non-insulin-dependent diabetes mellitus (NIDDM) patients at the level of the glucose-transport effector system. Freshly isolated adipocytes from obese nondiabetic and obese NIDDM subjects had decreased insulin sensitivity and responsiveness for glucose-transport stimulation compared with control subjects, with more pronounced changes associated with obese NIDDM patients. The relative abundance of muscle/fat glucose-transporter isoform in the three groups of subjects was determined by Western-blot analysis of detergent-soluble adipose tissue extracts with monoclonal antibody 1F8. Obesity per se had no effect on adipose tissue muscle/fat glucose-transporter isoform (3150 +/- 660 vs. 4495 +/- 410 counts/min [cpm]/mg protein). Furthermore, decreased levels of muscle/fat isoform in adipose tissue of NIDDM patients were also reflected in isolated adipocytes. Our results demonstrate that insulin resistance in isolated adipocytes of NIDDM patients could at least partly be due to a significant depletion of adipose tissue muscle/fat glucose-transporter isoform.
Similar articles
-
Decreased expression of glucose transporter in muscle from insulin-resistant patients.Am J Physiol. 1991 Mar;260(3 Pt 1):E459-63. doi: 10.1152/ajpendo.1991.260.3.E459. Am J Physiol. 1991. PMID: 2003599
-
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.J Clin Invest. 1991 Mar;87(3):1072-81. doi: 10.1172/JCI115068. J Clin Invest. 1991. PMID: 1999488 Free PMC article.
-
Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.Diabetes. 1992 Apr;41(4):465-75. doi: 10.2337/diab.41.4.465. Diabetes. 1992. PMID: 1535055
-
Regulation of glucose transport in skeletal muscle.FASEB J. 1992 Nov;6(14):3238-44. doi: 10.1096/fasebj.6.14.1426762. FASEB J. 1992. PMID: 1426762 Review.
-
Insulin resistance in type II diabetes mellitus.Adv Second Messenger Phosphoprotein Res. 1990;24:511-6. Adv Second Messenger Phosphoprotein Res. 1990. PMID: 2169826 Review.
Cited by
-
GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes.J Biol Chem. 2008 Mar 21;283(12):7429-37. doi: 10.1074/jbc.M800481200. Epub 2008 Jan 23. J Biol Chem. 2008. PMID: 18216015 Free PMC article.
-
Expression of human GLUT4 in mice results in increased insulin action.Diabetologia. 1994 Nov;37(11):1097-104. doi: 10.1007/BF00418373. Diabetologia. 1994. PMID: 7867881
-
Catch-up growth in juvenile rats, fat expansion, and dysregulation of visceral adipose tissue.Pediatr Res. 2022 Jan;91(1):107-115. doi: 10.1038/s41390-021-01422-9. Epub 2021 Mar 2. Pediatr Res. 2022. PMID: 33654281
-
Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.J Clin Invest. 1992 Feb;89(2):701-5. doi: 10.1172/JCI115638. J Clin Invest. 1992. PMID: 1737857 Free PMC article.
-
Transdermal delivery of insulin by amidated pectin hydrogel matrix patch in streptozotocin-induced diabetic rats: effects on some selected metabolic parameters.PLoS One. 2014 Jul 2;9(7):e101461. doi: 10.1371/journal.pone.0101461. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2021 Feb 11;16(2):e0247150. doi: 10.1371/journal.pone.0247150. PMID: 24987850 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical